講演情報
[F1-83]cCHPナノゲルを基盤としたRSV経鼻ワクチンの開発
Development of cCHP nanogel based nasal vaccine for RSV infection.
*Yohei Uchida1, Shingo Umemoto1,2, Rika Nakahashi1,3, Hiroshi Kiyono1,3,4,5,6,7 (1. Department of Human Mucosal Vaccinology, Chiba University Hospital (Japan), 2. Department of Otorhinolaryngology and Head & Neck Surgery, Faculty of Medicine, Oita University (Japan), 3. Synergy Institute for Futuristic Mucosal Vaccine Research and Development (cSIMVa), Chiba University (Japan), 4. Future Medicine Education and Research Organization, Chiba University (Japan), 5. Department of Medicine, UC San Diego School of Medicine (USA), 6. CU-UCSD Center for Mucosal Immunology, Allergy and Vaccines (cMAV), UC San Diego School of Medicine (USA), 7. Division of Infectious Disease Vaccine R&D, Research Institute of Disaster Medicine, Chiba University (Japan))
閲覧にはパスワードが必要です
ログイン
または
コメント
コメントの閲覧・投稿にはログインが必要です。ログイン